FDA panel to consider osteoarthritis drug tanezumab

By SASHA PEZENIK, ABC News (NEW YORK) -- A crucial vote of Food and Drug Administration advisory committee members is set for Thursday afternoon, and they could eventually determine whether some of the 32 million Americans suffering from osteoarthritis pain may find a... Read More.